Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients

American Journal of Nephrology

Volumn 33, Issue 3, 2011, Pages 224-230

  Scialla, Julia J ^a   Plantinga, Laura C ^e   Kao, W H Linda ^a,b,c   Jaar, Bernard ^a,b,c,d   Powe, Neil R ^e   Parekh, Rulan S ^a,b,f  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NEPHROLOGY CENTER OF MARYLAND   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cardiovascular disease; Dialysis; End stage renal disease; Inflammation; P selectin; Sudden cardiac death

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; INTERLEUKIN 6; PADGEM PROTEIN; SERUM ALBUMIN;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SUDDEN DEATH; THROMBOCYTE COUNT;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; P-SELECTIN; RENAL DIALYSIS;

EID: 79951857188     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324517     Document Type: Article

References (23)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-S119. (Pubitemid 28527268)
2. Parekh RS, Plantinga LC, Kao WHL, Meoni LA, Jaar BG, Fink NE, Powe NR, Coresh J, Klag MJ: The association of sudden cardiac death with inflammation and other tradi-tional risk factors. Kidney Int 2008; 74: 1335-1342.
3. Bonfanti R, Furie BC, Furie B, Wagner DD: PADGEM (GMP 140) is a component of Wei-bel-Palade bodies of human endothelial cells. Blood 1989; 73: 1109-1112. (Pubitemid 19107409)
4. Larsen E, Celi A, Gilbert GE, Furie BC, Er-ban JK, Bonfanti R, Wagner DD, Furie B: PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312. (Pubitemid 19264376)
5. Dole VS, Bergmeier W, Mitchell HA, Eichen-berger SC, Wagner DD: Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: Role of P-selectin. Blood 2005; 106: 2334-2339. (Pubitemid 41510804)
6. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, Croce K, Fu-rie BC, Furie B: Accumulation of tissue fac-tor into developing thrombi in vivo is depen-dent upon microparticle P-selectin glyco-protein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598. (Pubitemid 36682554)
7. Thijs A, Nanayakkara PWB, ter Wee PM, Huijgens PC, van Guldener C, Stehouwer CDA: Mild-to-moderate renal impairment is associated with platelet activation: a cross-sectional study. Clinical Nephrology 2008; 70: 325-331.
8. Stasko J, Galajda P, Ivankova J, Holly P, Roz-borilova E, Kubisz P: Soluble P-selectin dur-ing a single hemodialysis session in patients with chronic renal failure and erythropoie-tin treatment. Clin Appl Thromb Hemost 2007; 13: 410-415. (Pubitemid 350114513)
9. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ: Tradition-al cardiovascular disease risk factors in di-alysis patients compared with the general population: the choice study. J Am Soc Nephrol 2002; 13: 1918-1927. (Pubitemid 34700618)
10. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ: Association between cholesterol level and mortality in dialysis patients: role of in-flammation and malnutrition. JAMA 2004; 291: 451-459. (Pubitemid 38129749)
11. Longenecker JC, Klag MJ, Marcovina SM, Liu YM, Jaar BG, Powe NR Fink NE, Levey AS, Coresh J: High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis pa-tients. J Am Soc Nephrol 2005; 16: 1794-1802. (Pubitemid 41716486)
12. Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, Melamed ML, Powe NR Jaar BG: Peripheral vascular disease-related proce-dures in dialysis patients: predictors and prognosis. Clin J Am Soc Nephrol 2009; 4: 1637-1645.
13. Dong ZM, Brown AA, Wagner DD: Promi-nent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 2000; 101: 2290-2295. (Pubitemid 30317132)
14. Burger PC, Wagner DD: Platelet P-selectin facilitates atherosclerotic lesion develop-ment. Blood 2003; 101: 2661-2666. (Pubitemid 36857627)
15. Kisucka J, Chauhan AK, Zhao B-Q, Patten IS, Yesilaltay A, Krieger M, Wagner DD: El-evated levels of soluble P-selectin in mice al-ter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 2009; 113: 6015-6022.
16. Guardamagna O, Abello F, Saracco P, Barac-co V, Rolfo E, Pirro M: Endothelial activa-tion, inflammation and premature athero-sclerosis in children with familial dyslipid-emia. Atherosclerosis 2009; 207: 471-475.
17. Reiner AP, Carlson CS, Thyagarajan B, Rie-der MJ, Polak JF, Siscovick DS, Nickerson DA, Jacobs DR Jr, Gross MD: Soluble P-selec-tin, SELP polymorphisms, and atheroscle-rotic risk in European-American and Afri-can-African young adults: the Coronary Ar-tery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 2008; 28: 1549-1555.
18. Varughese GI, Patel JV, Tomson J, Blann AD, Hughes EA, Lip GY: Prognostic value of plas-ma soluble P-selectin and von Willebrand factor as indices of platelet activation and en-dothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. J Int Med 2007; 261: 384-391. (Pubitemid 46474757)
19. Schwartz RS, Burke A, Farb A, Kaye D, Les-ser JR, Henry TD, Virmani R: Microemboli and microvascular obstruction in acute cor-onary thrombosis and sudden coronary death: relation to epicardial plaque histopa-thology. J Am Coll Cardiol 2009; 54: 2167-2173.
20. Goldstein JA, Butterfield MC, Ohnishi Y Shelton TJ, Corr PB: Arrhythmogenic in-fluence of intracoronary thrombosis dur-ing acute myocardial ischemia. Circulation 1994; 90: 139-147. (Pubitemid 24203673)
21. Kälsch T, Elmas E, Nguyen XD, Wolpert C, Klüter H, Borggrefe M, Haase KK, Dempfle CE: Enhanced expression of platelet CD40-ligand by in vitro lipopolysaccharide-chal-lenge in patients with ventricular fibrillation complicating acute myocardial infarction. Int J Cardiol 2006; 107: 350-355. (Pubitemid 43287780)
22. Elmas E, Bugert P, Popp T, Lang S, Weiss C, Behnes M, Borggrefe M, Kälsch T: The P-se-lectin gene polymorphism Val168Met: a nov-el risk marker for the occurrence of primary ventricular fibrillation during acute myocar-dial infarction. J Cardiovasc Electrophysi-ol;21: 1260-1265.
23. Villar IC, Hobbs AJ, Ahluwalia A: Sex differ-ences in vascular function: implication of endothelium-derived hyperpolarizing fac-tor. J Endocrinol 2008; 197: 447-462. (Pubitemid 351803950)